Mark Schoenberg - 31 Jan 2024 Form 4/A Insider Report for UroGen Pharma Ltd. (URGN)

Signature
/s/ Jason D. Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
31 Jan 2024
Net transactions value
-$59,790
Form type
4/A
Filing time
05 Feb 2024, 21:15:14 UTC
Date Of Original Report
02 Feb 2024
Previous filing
08 Sep 2023
Next filing
20 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Sale $17,942 -1,137 -0.76% $15.78 149,423 01 Feb 2024 Direct F1, F2
transaction URGN Ordinary Shares Sale $11,961 -758 -0.5% $15.78 149,998 01 Feb 2024 Direct F1, F2
transaction URGN Ordinary Shares Sale $29,887 -1,894 -1.2% $15.78 151,437 01 Feb 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024.
F2 This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024.